Ton Van 't Hullenaar

Responsible for 13 European countries, including UK and Germany.

Turnover 1.7 Billion US $

Ebitda 500+ Million US

Employees 4000.

Most important activities:

Coach and monitor Countrymanagers and their teams to make sure targets are met.

Integrate the Meda acquisition within Mylan.

Responsible for 70% of the global Meda business.

Most important activities:

Integration of several acquisitions ( 3M pharmaceuticals, Valeant Europe, Rottapharm and some smaller companies).

Make sure that plans are implemented and realized.

In all cases work with less people, cutting budgets and still maintaining or grow organic sales and increase profits dramatically .

Coach and monitor countries/managers in my area and review results monthly and ftf quarterly .

Make sure to have the right management teams in place.

Sales 1.3 billion, Ebitda 33%

3M was my first employer where I started in 1980 as a pharmaceutical salesrep and via many steps in between ( Sales & Marketing Manager NL, Businesshead Healthcare Benelux, Pharmadirector Germany, Healthcare director Germany) I became the business director Pharmaceuticals Europe and was the lead person for Europe when 3M decided to divest Pharmaceuticals.